Vitamin D supplements during pregnancy

Phase 2

Not yet recruiting

• Registration Number: CTRI/2022/01/039091
• Lead Sponsor: Medical Research Council

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Apparent healthy pregnant woman (18-40 years), before 13 weeks of gestation, willing to give informed consent, oblige to protocol regime, consume assigned supplement, and give blood samples.

Exclusion Criteria

Pregnant women with twins or multiple pregnancies, chronic morbidities, on medication or undergoing treatment, or consuming multi-vitamins, have infections such as HIV, VDRL, HBsAg, assisted pregnancy, or anticipate discontinuing or moving out of the study site.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To perform an open label study of 2000IU vitamin D3/d supplementation <br/ ><br> <br/ ><br>from second trimester of pregnancy until delivery to determine whether <br/ ><br> <br/ ><br>this supplemental dose results in vitamin D repletion after interventionTimepoint: Assessment of Total Vitamin D, PTH levels in maternal venous blood during pregnancy (14, 24 and 34 weeks of gestation). <br/ ><br> <br/ ><br>from second trimester of pregnancy until delivery to determine whether <br/ ><br> <br/ ><br>this supplemental dose results in vitamin D repletion after intervention